Saturday, October 10
Drugmaker Wockhardt on Friday said its novel antibiotic Zaynich has an addressable market opportunity of USD 7 billion in the US and Europe. The company said it has completed a pre-NDA (non-disclosure agreement) meeting with the US Food and Drug Administration (USFDA) in May 2025. Filing to the USFDA is slated in the second quarter of the current fiscal with potential launch in FY2026-27, Wockhardt Ltd said in a regulatory filing. The company plans for regulatory approval for the product in Europe and emerging markets in the second half of the current financial year, it added. Wockhardt said it has also filed for approval of Zaynich with the Drug Controller General of India (DCGI) and expects to launch the product in the domestic market in the second half of the current fiscal. The antibio
Mumbai: Promoters' stake pledges went up for 27 companies out of the Nifty 500 companies during January-March, compared with 25 companies in the previous quarter, according to data from Primedatabase. Aadhar Housing Finance, Max Financial Services and Raymond Lifestyles were among the companies that saw promoters pledging their holdings during the quarter.Promoters, or shareholders, put up their shares as collateral for loans. While promoters placing their shares as collateral is not uncommon, sudden increases in such pledging catch the attention of the investor community."Pledging of shares in itself is not necessarily a concern and may be a means of leveraging the stake when markets are performing well," said Abhilash Pagaria, head of Alternative and Quantitative Research, Nuvama. "Howev
Mumbai: Many high-net-worth individuals (HNIs) in India may be falling short of meeting their financial goals, according to a survey conducted by Marcellus Investment Managers and Dun & Bradstreet.The survey, conducted in February-March 2025, covering 465 respondents across metros and tier 1 and 2 cities, all with post-tax household incomes of over ₹20 lakh per annum, said these affluent individuals might not be saving enough.While 43% of HNIs surveyed save less than 20% of their post-tax income, HNIs face challenges in achieving their goals because of low investment returns, lack of savings discipline, poor understanding of investment options and high debt burden.121634933Four in 10 respondents have at least one open loan. While real estate dominates portfolios - with half allocatin
